疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2014年
11期
1146-1148
,共3页
胃癌,晚期%腹腔积液%化疗,循环热灌注
胃癌,晚期%腹腔積液%化療,循環熱灌註
위암,만기%복강적액%화료,순배열관주
Gastric cancer,advanced%Ascites%Chemotherapy%Coelom continued circulatory hyperthermia perfusion
目的:观察循环热灌注化疗对晚期胃癌合并腹腔积液患者的临床效果。方法选取2013年4月—2014年5月就诊的晚期胃癌合并腹腔积液患者110例作为研究对象,随机分为对照组( n =56)和观察组( n =54),对照组患者采用常规化疗,观察组患者采用循环热灌注化疗,对比分析2组患者的临床治疗效果、生活改善情况和不良反应发生率。结果观察组患者的总有效率明显高于对照组患者(78§.63%vs.55.36%, P <0.01),且观察组患者的生活质量改善率明显高于对照组患者(59.26%vs.37.50%, P <0.05)。对照组不良反应发生率为53.57(30/56),观察组为51.85%(28/54),2组比较差异无统计学意义( P >0.05)。结论晚期胃癌合并腹腔积液患者采用循环热灌注化疗,能明显提高总有效率,在一定程度上改善患者的生活质量。
目的:觀察循環熱灌註化療對晚期胃癌閤併腹腔積液患者的臨床效果。方法選取2013年4月—2014年5月就診的晚期胃癌閤併腹腔積液患者110例作為研究對象,隨機分為對照組( n =56)和觀察組( n =54),對照組患者採用常規化療,觀察組患者採用循環熱灌註化療,對比分析2組患者的臨床治療效果、生活改善情況和不良反應髮生率。結果觀察組患者的總有效率明顯高于對照組患者(78§.63%vs.55.36%, P <0.01),且觀察組患者的生活質量改善率明顯高于對照組患者(59.26%vs.37.50%, P <0.05)。對照組不良反應髮生率為53.57(30/56),觀察組為51.85%(28/54),2組比較差異無統計學意義( P >0.05)。結論晚期胃癌閤併腹腔積液患者採用循環熱灌註化療,能明顯提高總有效率,在一定程度上改善患者的生活質量。
목적:관찰순배열관주화료대만기위암합병복강적액환자적림상효과。방법선취2013년4월—2014년5월취진적만기위암합병복강적액환자110례작위연구대상,수궤분위대조조( n =56)화관찰조( n =54),대조조환자채용상규화료,관찰조환자채용순배열관주화료,대비분석2조환자적림상치료효과、생활개선정황화불량반응발생솔。결과관찰조환자적총유효솔명현고우대조조환자(78§.63%vs.55.36%, P <0.01),차관찰조환자적생활질량개선솔명현고우대조조환자(59.26%vs.37.50%, P <0.05)。대조조불량반응발생솔위53.57(30/56),관찰조위51.85%(28/54),2조비교차이무통계학의의( P >0.05)。결론만기위암합병복강적액환자채용순배열관주화료,능명현제고총유효솔,재일정정도상개선환자적생활질량。
Objective To observe the effect of cyclic heat perfusion chemotherapy on patients with advanced gastric cancer with peritoneal effusion .Methods From 2013 April to 2014 May, 110 cases of patients with advanced gastric cancer with peritoneal effusion were enrolled as the research object , they were randomly divided into control group ( n =56) and ob-servation group ( n =54 ) , the control group was treated with conventional chemotherapy , patients in the observation group u-sing coelom continued circulatory hyperthermia perfusion .Clinical therapeutic effect , improvement of life , and the incidence of adverse reaction were compared between the 2 groups.Results The observation group’s total effective rate was significantly higher than that of the control group patients (78.63%vs.55.36%, P <0.01,) and the observation group patients life quali-ty improvement rate was significantly higher than that of patients in the control group (59.26%vs.37.50%, P <0.05).The control group ’ s incidence of adverse reaction was 53 .57% ( 30/56 ) , the observation group was 51 .85% ( 28/54 ) , the differences between the 2 groups revealed no statistical significance ( P >0.05).Conclusion Coelom continued circulatory hyperthermia perfusion for advanced gastric cancer patients complicated with ascites can significantly improve the total efficien -cy and the quality of life in certain extent .